When You Disagree With a Treatment Plan: How to Keep the Conversation Open

Agreement is not the same thing as good care

A clinician recommends a medication.

You are not convinced.

Perhaps you are worried about side effects.

Perhaps you tried something similar before and felt worse.

Perhaps the treatment is expensive, incompatible with your work, difficult to take regularly or simply does not fit what matters most to you.

Perhaps you understand the recommendation perfectly and still do not want it.

Healthcare has often described situations like this using words such as compliance and noncompliance.

Those words can be useful in narrow technical contexts, but they can also hide the most important question:

Why does the plan not work for this person?

A treatment can be medically reasonable and still fail in real life if the patient cannot, does not or will not follow it.

That is not a reason to abandon medical expertise.

It is a reason to make the disagreement visible enough to understand.

You are allowed to have a preference

Shared decision-making does not mean that the patient and clinician bring identical expertise.

The clinician brings knowledge about diagnosis, prognosis, treatment options, likely benefits, harms and uncertainty.

You bring knowledge that no scan, laboratory result or guideline can provide on its own:

• what you value;
• what you fear;
• what you have experienced before;
• what your daily life can realistically sustain;
• what trade-offs you are willing to make;
• and what outcomes matter enough to you to justify treatment burden or risk.

Good decisions require both kinds of information.

NICE guidance on shared decision-making explicitly recommends discussing how treatment options align with a person’s aims, priorities and wider goals, including the possibility of choosing no treatment or no change when that is clinically relevant.

That does not mean every option is equally safe or effective.

It means your values belong in the decision.

Start by finding out what you are actually disagreeing about

Sometimes a treatment disagreement is really an information problem.

You may think the medication is intended to cure a condition when the clinician is prescribing it only to reduce future risk.

You may believe a side effect is inevitable when it is uncommon.

You may have heard that stopping a drug is dangerous when the advice actually applies only to abrupt discontinuation.

Or the clinician may assume you are refusing because you do not understand, when you understand very well and simply weigh the trade-offs differently.

Before arguing about the decision, clarify the decision itself.

Useful questions include:

• What is this treatment meant to achieve?
• How likely is it to help me?
• What are the important risks or side effects?
• What happens if I wait?
• What are the alternatives?
• Is doing nothing for now a reasonable option?
• How will we know whether it is working?

You do not need to ask all of them.

Ask the ones that change the choice.

Say what the barrier really is

Clinicians cannot respond to a reason they do not know.

If the real problem is cost, say cost.

If it is fear, say fear.

If the schedule is impossible, say that.

If the medication reminds you of a previous bad experience, explain it.

If taking treatment at work would reveal a condition you have kept private, that matters.

If you are simply not willing to accept a particular risk for the expected benefit, that matters too.

The World Health Organization has long emphasized that adherence is affected by much more than patient motivation. Treatment complexity, communication, the healthcare system, the patient–provider relationship and the fit between a regimen and a person’s life can all matter.

A useful sentence is:

“I understand why you are recommending this. The part that makes it difficult for me is…”

That moves the conversation from resistance to a solvable—or at least nameable—problem.

“I’m worried about side effects” deserves more than reassurance

Side-effect discussions often fail because the two people are answering different questions.

The clinician may hear:

Is this side effect common?

The patient may mean:

If this happens to me, can I still work, drive, care for my child or live normally?

Ask for information in a form that helps you decide:

• How common is the effect?
• How serious is it?
• Is it temporary or persistent?
• What should I do if it happens?
• Is there another option with a different trade-off?

A low-probability side effect can still matter greatly if its consequences are especially important in your life.

Risk is not only a number.

It is a number attached to a consequence.

If you have already stopped or changed the treatment, say so

Patients sometimes hide non-adherence because they expect to be judged.

That creates a clinical problem.

If the clinician believes you are taking a medication that you stopped weeks ago, they may interpret symptoms, test results or treatment failure incorrectly.

You do not need to present the information as a confession.

State it as medically relevant data:

“I stopped taking it five days ago because the dizziness was interfering with work.”

or:

“I have only been taking it about three times a week. I was worried about the effect on my kidneys.”

That gives the clinician something concrete to work with.

It may reveal a misunderstanding, a side effect, a practical barrier or a need for a different plan.

Understanding a recommendation does not obligate you to choose it

A genuinely shared decision has room for disagreement.

NICE guidance explicitly advises clinicians to acknowledge that patients and healthcare professionals may weigh risks, benefits and consequences differently.

That is important.

Sometimes the disagreement remains after the facts are clear.

The clinician may believe treatment A offers the best medical balance.

You may decide that its burden or risk is not acceptable to you.

Where you have decision-making capacity and the choice is legally yours, informed refusal is not the same as misunderstanding.

The clinician’s job is still to explain the consequences honestly and recommend what they believe is medically appropriate.

Your job is not to make the clinician comfortable by agreeing.

Your responsibility is to make the decision as informed as possible and communicate it clearly enough that care can continue safely.

But autonomy is not a guarantee that every request can be provided

There is another side to this.

Being involved in decisions does not mean a clinician must prescribe a treatment they believe is unsafe, ineffective or outside appropriate practice.

You can refuse a recommended antibiotic.

That does not automatically create an entitlement to a different antibiotic the clinician believes is unnecessary.

You can decline an investigation.

That does not require the clinician to pretend there is no resulting uncertainty.

Shared decision-making works inside professional and safety boundaries.

The goal is not “the patient gets what they want.”

It is the decision is made with the relevant evidence, preferences, constraints and responsibilities visible.

Ask what would change the recommendation

When you and the clinician disagree, a powerful question is:

“What would make you change your mind?”

Then answer it yourself:

“What would make me change mine?”

Perhaps the clinician would recommend watchful waiting if a test is reassuring.

Perhaps you would accept treatment if your symptoms worsen or a particular risk becomes more likely.

Perhaps both of you can agree on a time-limited trial.

Perhaps there is no middle ground—but even then, understanding the threshold for reconsideration creates a clearer plan.

A second opinion can be useful without becoming a search for agreement

A second opinion is reasonable when:

• the decision is high stakes;
• the diagnosis is uncertain;
• several reasonable options exist;
• you do not understand why a major intervention is being recommended;
• or the relationship has become so strained that productive discussion is difficult.

The purpose is not necessarily to find someone who will say yes.

It is to obtain another clinical assessment and another explanation of the options.

If two clinicians independently explain the same concern, that is useful information.

If they disagree, that is useful information too.

If the conversation becomes tense, name the disagreement

You do not need to win an argument in the consulting room.

Try making the difference explicit:

“I think we agree about the diagnosis, but not about whether the benefit of this treatment is worth the side effects to me.”

or:

“I don’t think I understand what you believe is likely to happen if I wait.”

or:

“I hear that you strongly recommend this. I’m not ready to agree today. Can we make a safe plan while I think about it?”

This helps separate three different problems:

information, preference, and relationship.

They require different solutions.

Leave with an explicit plan, even when the answer is no

A disagreement should not end with ambiguity.

Before the consultation ends, clarify:

• What have I decided for now?
• What does the clinician recommend?
• What risks should I watch for?
• What would make the situation urgent?
• Is there another option to try?
• When will we review the decision?
• Can I change my mind later?

NICE shared decision-making guidance recommends ending discussions with a clear shared understanding of what was decided, what happens next, the timescale and when the plan will be reviewed.

That is especially important after disagreement.

A patient who declines one recommendation still needs care.

If you feel you are being labelled

Words such as noncompliant, difficult or refusing can make a complex situation sound like a character flaw.

Sometimes the record needs to document that a recommended treatment was declined or not followed. That can be clinically important.

But the useful information is usually the reason:

• treatment caused intolerable side effects;
• patient could not afford medication;
• dosing schedule was incompatible with work;
• patient understood expected benefit and declined because of stated preference;
• instructions were misunderstood;
• follow-up was inaccessible;
• patient wanted additional information before deciding.

Those descriptions tell the next clinician what happened.

A label alone does not.

If you think the record or conversation is misrepresenting your decision, you can calmly ask:

“Could we document why I’m choosing not to do this, not only that I declined it?”

The central idea

You and your clinician do not need to agree about everything for the relationship to remain useful.

But hidden disagreement is dangerous.

If you are worried, say what you are worried about.

If the plan is impossible, say why.

If you do not understand, ask again.

If you understand and still choose differently, make that clear.

And if the clinician believes your choice carries significant risk, ask them to explain that risk plainly and help you make the safest possible plan from where you actually are—not from where either of you wishes the decision had ended.

Good clinical empathy does not erase disagreement.

It makes disagreement discussable.

Selected evidence

National Institute for Health and Care Excellence (NICE). Shared decision making. NICE guideline NG197. 2021, updated guidance online.

National Institute for Health and Care Excellence (NICE). Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical guideline CG76. 2009, updated guidance online.

World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003.

Joosten EAG, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychotherapy and Psychosomatics. 2008;77(4):219–226.

Source-corpus note

The editorial starting point for this Resource included an uploaded 2012 news article about Czech rules concerning patients described as “uncompliant,” alongside an uploaded clinical-communication source emphasizing patient involvement in treatment decisions. Their dated framing was not adopted as contemporary guidance; it was used to identify the underlying tension between responsibility, autonomy, communication and coercion.